Pharma major Dr. Reddy’s Laboratories on Monday said safety data pertaining to phase-2 clinical trial of Russia’s Sputnik-V COVID-19 vaccine candidate
from The Hindu - Home https://ift.tt/38Clqhn
from SEO Tech Tips https://ift.tt/3oBEGRC
Unknown Pharma major Dr. Reddy’s Laboratories on Monday said safety data pertaining to phase-2 clinical trial of Russia’s Sputnik-V COVID-19 vaccine candidate
from The Hindu - Home https://ift.tt/38Clqhn
https://ift.tt/eA8V8J January 12, 2021 at 05:32AM https://ift.tt/2yfVyVV
Tuesday, January 12, 2021
Dr. Reddy’s seeks DCGI nod for Sputnik-V phase-3 trials
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment